Patent application number | Description | Published |
20090082560 | AMINODIHYDROTHIAZINE DERIVATIVES - A composition having BACE 1 inhibitory activity containing a compound represented by the general formula (I): | 03-26-2009 |
20100160290 | PHARMACEUTICAL COMPOSITION FOR TREATING ALZHEIMER'S DISEASE - A pharmaceutical composition for treating Alzheimer's disease containing a compound represented by the general formula (I); | 06-24-2010 |
20110190279 | SULFUR-CONTAINING HETEROCYCLIC DERIVATIVE HAVING BETA SECRETASE INHIBITORY ACTIVITY - The following compound is provided as an agent for treating a disease induced by production, secretion and/or deposition of amyloid β protein, for example, a compound represented by the formula (I): | 08-04-2011 |
20120015961 | ISOTHIOUREA DERIVATIVES OR ISOUREA DERIVATIVES HAVING BACE1 INHIBITORY ACTIVITY - The present invention provides, for example, a compound of the following formula (I): | 01-19-2012 |
20120245154 | SUBSTITUTED AMINOTHIAZINE DERIVATIVE - The present invention relates to an agent for treating or preventing disease induced by production, secretion and/or deposition of amyloid β protein, for example, a compound of formula (I), wherein, R | 09-27-2012 |
20120245157 | OXAZINE DERIVATIVES - The present invention provides, for example, a compound mentioned below as a medicament for treating or preventing the diseases induced by production, secretion or deposition of amyloid-β proteins. | 09-27-2012 |
20140058097 | PHARMACEUTICAL COMPOSITION FOR TREATING ALZHEIMER'S DISEASE - A pharmaceutical composition for treating Alzheimer's disease containing a compound represented by the general formula (I): | 02-27-2014 |
Patent application number | Description | Published |
20090169610 | Liposome Preparation - The present invention provides cancer treatment preparations of excellent targetability. The sugar chain-modified liposomes of the present invention, which contain an aromatase inhibitor, anti-androgenic agent, lyase inhibitor, GnRH agonist, GnRH antagonist, anti-angiogenic agent, tyrosine kinase inhibitor, serine-threonine kinase inhibitor, antibody having an anticancer activity, ansamitocin, capecitabine, celmoleukin, docetaxel hydrate, gemcitabine hydrochloride, oxaliplatin, prednisolone, tegafur-uracil mixtures, zinostatin stimalamer or arsenic trioxide may be used as cancer treatment preparations having an excellent targetability. | 07-02-2009 |
Patent application number | Description | Published |
20090054279 | Two-Component Anti-Seizure Agent for Hot Metal Working Process, and Method of Manufacturing Seamless Pipe Using Thereof - The present invention provide a two-component anti-seizure agent for hot metal working process comprising the first aqueous solution and the second aqueous solution, wherein the first aqueous solution contains 10˜30 mass % of sodium silicate equivalent to anhydride to 100 mass % of total mass of the first aqueous solution, and the second aqueous solution contains at least one kind selected from a group consisting of: an organic acid and water-soluble amine salts thereof, an inorganic acid and water-soluble amine salts thereof, a water-soluble amine, a water-soluble alcohol, and a water-soluble metal chloride. When the two-component anti-seizure agent is applied onto disk-roll type guide shoes, it can be provided and maintained on the circumferential surface of the disk-roll type guide shoes without washed away by rolls' cooling water. Thereby, the anti-seizure agent does not adhere to rolls and the rolls and a pipe material do not cause slippage each other. Thus, it is capable to carry out piercing-rolling of the pipe material. | 02-26-2009 |
20090297717 | Anti-Seizure Agent for Hot Steel Working - An anti-seizure agent for hot steel working that exhibits excellent wettability and surface film-adherability comprises: an inorganic component (first component); sodium hydroxide (second component); water-soluble resins and/or water-soluble surfactants (third component); and water. With the mass of the sum of the first component, the second component, and the third component as 100 mass %, the anti-seizure agent contains: 96.5 mass % or more and 99.98 mass % or less of the first component; 0.01 mass % or more and 2.0 mass % or less of the second component; and 0.01 mass % or more and 1.5 mass % or less of the third component, and the inorganic component is one or more selected from a group consisting of Al | 12-03-2009 |
20120304722 | ANTI-SEIZURE AGENT FOR HOT STEEL WORKING - A method of coating uses an anti-seizure agent for hot steel working that exhibits excellent wettability and surface film-adherability. The agent comprises: an inorganic component (first component); sodium hydroxide (second component); water-soluble resins and/or water-soluble surfactants (third component); and water. With the sum of the first component, the second component, and the third component as 100 mass %, the anti-seizure agent contains: 96.5 mass % or more and 99.98 mass % or less of the first component; 0.01 mass % or more and 2.0 mass % or less of the second component; and 0.01 mass % or more and 1.5 mass % or less of the third component, and the inorganic component is one or more selected from a group consisting of Al | 12-06-2012 |
Patent application number | Description | Published |
20090074600 | ROTARY COMPRESSOR - A bolt hole receiving a fixing bolt is formed in a portion of an end plate overlapping an annular piston or a fixed wrap as viewed in a thickness direction of the end plate to open at the back face of the end plate. In fixing a discharge valve o the end plate, the fixing bolt is screwed into the bolt hole. | 03-19-2009 |
20090142214 | ROTARY COMPRESSOR - In a compression mechanism of a rotary compressor, a cylinder chamber is defined by a cylinder and a second housing. A back surface side gap is defined between an end plate part of the cylinder and a flat plate part of a first housing. The first housing is provided with a communicating path and a differential pressure regulating valve. When the difference between the suction pressure and the discharge pressure is small, the discharge pressure is introduced through the communicating path to an intermediate gap whereby both an internal gap and the intermediate gap are placed at the same pressure as the discharge pressure. Conversely, when the difference between the discharge pressure and the suction pressure is great, the communicating path is made discontinuous by the differential pressure regulating valve whereby the intermediate gap is placed at an intermediate pressure lower than the discharge pressure. | 06-04-2009 |
20090148325 | ROTARY TYPE COMPRESSOR - A valve guard for restricting the amount of deformation of a valve disc has a main body part abuttable with the back surface of the valve disc, and a fixation part extending to outside of a receding part. Upon mounting the valve guard to an end plate part, the fixation part is firmly attached to the outside of the receding part of the end plate part. | 06-11-2009 |
20090277216 | ROTARY COMPRESSOR - A bolt hole receiving a fixing bolt is formed in a portion of an end plate overlapping an annular piston or a fixed wrap as viewed in a thickness direction of the end plate to open at the back face of the end plate. In fixing a discharge valve to the end plate, the fixing bolt is screwed into the bolt hole. | 11-12-2009 |
20120087819 | ROTARY COMPRESSOR - A high pressure dome type rotary compressor including a casing and a compression mechanism disposed in the casing to compress gas in a cylinder chamber. The compression mechanism has a discharge port and a discharge valve. The discharge valve is opened in a discharge process and is closed during a period from when the discharge process is finished to when a next compression process is started. The compressor is arranged such that high pressure gas discharged from the discharge port in the discharge process is discharged outside the casing through space in the casing. An oil feed path is arranged to feed lubricant oil contained in a bottom of the casing to an inside of the discharge port in a period from a point in time in the discharge process to when the compression process is started. | 04-12-2012 |
Patent application number | Description | Published |
20090007577 | ROTATION SPEED CONTROL DEVICE, AIR CONDITIONER, AND ROTATION SPEED CONTROL METHOD - An outdoor control unit includes a first control unit, a second control unit, and a switching unit. The outdoor control unit controls the rotational speed of an outdoor fan. The first control unit executes a first control for controlling the rotational speed of the outdoor fan based on the operation frequency of the compressor. The second control unit executes a second control for controlling the rotational speed of the outdoor fan based on a parameter other than the operation frequency of the compressor. The switching unit executes a switching control for switching between the first control and the second control according to a predetermined switching condition, when a cooling mode is being operated under a low outside air condition. The low outside air condition refers to a state that the outside air temperature is lower than a first temperature. | 01-08-2009 |
20090019868 | AIR CONDITIONER - An outdoor unit of an air conditioner includes a plurality of constant capacity compressors, a variable capacity compressor and a controller. The plurality of constant capacity compressors compress refrigerant in a predetermined capacity. The variable capacity compressor is capable of having its capacity changed and compressing varying amounts of refrigerant. The controller sequentially causes the plurality of constant capacity compressors to start up and regulates the operating frequency of the variable capacity compressor after start up of the plurality of constant capacity compressors. | 01-22-2009 |
20090019872 | AIR CONDITIONING APPARATUS - An air conditioning apparatus includes a refrigerant circuit and an operation control section. The operation control section is capable of performing a refrigeration cycle for causing an outdoor heat exchanger to function as a refrigerant condenser and an indoor heat exchanger to function as a refrigerant evaporator, while performing superheat degree control for controlling the aperture of an indoor expansion valve so that the degree of superheat of the refrigerant at the outlet from the indoor heat exchanger is constant. The operation control section sets a lower aperture limit for the indoor expansion valve to perform the superheat degree control, and reduces the lower aperture limit when the refrigerant at the outlet from the indoor heat exchanger is detected to be wet. | 01-22-2009 |
20090056358 | AIR CONDITIONER AND HEAT SOURCE UNIT - An air conditioner is provided with a plurality of outdoor units, an indoor unit, a liquid refrigerant communication pipe and gas refrigerant communication pipe, and a controller. The outdoor unit has a compressor, an outdoor heat exchanger, and an accumulator. The indoor unit has an indoor expansion valve and an indoor heat exchanger. The controller starts another of the heat source units in a stopped state when it is determined that the amount of refrigerant is excessive in a heat source unit in an operating state, or performs refrigerant accumulation control for accumulating refrigerant in an accumulator in a heat source unit other than a first heat source unit in an operating state. | 03-05-2009 |
20100243749 | HUMIDITY CONTROL APPARATUS - During a simple ventilation operation, in an outdoor-air conditioner ( | 09-30-2010 |
20100252642 | HUMIDITY CONTROL APPARATUS - A humidity control apparatus ( | 10-07-2010 |
20100257885 | HUMIDITY CONTROL APPARATUS - A humidity control apparatus ( | 10-14-2010 |
Patent application number | Description | Published |
20110223236 | SELEGILINE-CONTAINING ADHESIVE PREPARATION - The present invention provides an adhesive preparation, which includes a backing and a pressure-sensitive adhesive layer formed on at least one side of the backing, the pressure-sensitive adhesive layer containing (−)-(R)—N,α-dimethyl-N-2-propynylphenethylamine and/or a pharmaceutically acceptable salt thereof, a pressure-sensitive adhesive and a component which is liquid at 25° C. and has two or more ester bonds in one molecule thereof. | 09-15-2011 |
20110223237 | SELEGILINE-CONTAINING ADHESIVE PREPARATION - The present invention provides an adhesive preparation, which includes a backing and a pressure-sensitive adhesive layer formed on at least one side of the backing, the pressure-sensitive adhesive layer containing (−)-(R)—N,α-dimethyl-N-2-propynylphenethylamine and/or a pharmaceutically acceptable salt thereof, a pressure-sensitive adhesive, an antioxidant and a metal hydroxide. | 09-15-2011 |
20120294894 | PHARMACEUTICAL COMPOSITION AND METHOD FOR PRODUCING THE SAME - An object of the present invention is to provide a pharmaceutical composition that allows stable storage and delivery of heat-labile allergens. The present invention provides a pharmaceutical composition containing: an allergen; and at least one selected from the group consisting of an organic acid salt, an inorganic acid salt, and a pH adjuster. | 11-22-2012 |
20130177594 | PHARMACEUTICAL COMPOSITION AND METHOD FOR PRODUCING THE SAME - The present invention provides a pharmaceutical composition capable of preserving and delivering an allergen having poor thermal stability without using gelatin as a stabilizer, and a method for producing the pharmaceutical composition. The present invention provides a pharmaceutical composition containing an allergen and additives selected from at least two groups from among group (A) consisting of polysaccharides having high formability; group (B) consisting of mono- to hexasaccharides, sugar alcohols thereof, maltodextrin, and polyvinylpyrrolidone; and group (C) consisting of viscous polysaccharides; wherein the additives have a stabilizing effect on the allergen. | 07-11-2013 |
20130266612 | VACCINE COMPOSITION - An intraorally administrable vaccine composition useful to be a preventive or therapeutic agent for infectious diseases, and effectively induces a systemic immune response or a mucosal immune response is provided. A vaccine composition for administration to the oral cavity of a human or an animal, the vaccine composition containing at least one antigen derived from an infectious disease, and at least one selected from the group consisting of a toll-like receptor 4 (TLR4) agonist, a toll-like receptor 2/6 (TLR2/6) agonist, and cyclic dinucleotide, or a derivative or salt thereof. | 10-10-2013 |
20140220055 | WT1 PEPTIDE CANCER VACCINE COMPOSITION FOR TRANSDERMAL ADMINISTRATION - The present invention provides a cancer vaccine composition for transdermal administration for inducing cellular immunity, comprising (i) a WT1 peptide and/or a modified WT1 peptide; and (ii) a cellular immunity induction promoter. The composition efficiently induces cellular immunity against a cancer in a subject. | 08-07-2014 |
20140220056 | VACCINE COMPOSITION FOR TRANSDERMAL ADMINISTRATION - Disclosed is a vaccine composition for transdermal administration to induce cellular immunity, comprising an antigen, wherein Th1 cell ratio in a model animal for immunological evaluation that received the composition is 10% or more. | 08-07-2014 |
20140220057 | WT1 PEPTIDE CANCER VACCINE COMPOSITION FOR TRANSDERMAL ADMINISTRATION - The present invention provides a cancer vaccine composition for transdermal administration for cellular immunity induction, comprising (i) a WT1 peptide and/or a modified WT1 peptide; and (ii) a pharmacologically acceptable acid as a first cellular immunity induction promoter, or a pharmacologically acceptable salt thereof. | 08-07-2014 |
20140220058 | VACCINE COMPOSITION FOR TRANSDERMAL OR MUCOSAL ADMINISTRATION - The invention provides a vaccine composition for transdermal or transmucosal administration for inducing cellular immunity, comprising (i) an antigen; and (ii) a pharmacologically acceptable acid or a pharmacologically acceptable salt thereof as a first cellular immunity induction promoter. | 08-07-2014 |
20140220059 | WT1 PEPTIDE CANCER VACCINE COMPOSITION FOR MUCOSAL ADMINISTRATION - The present invention provides a cancer vaccine composition for mucosal administration for inducing cellular immunity, comprising (i) a WT1 peptide and/or a modified WT1 peptide; and (ii) a cellular immunity induction promoter. The composition efficiently induces cellular immunity against a cancer in a subject. | 08-07-2014 |
20140220063 | VACCINE COMPOSITION - The invention provides a vaccine composition containing an antigen for inducing cellular immunity, comprising at least one first cellular immunity induction promoter. | 08-07-2014 |
20140220079 | VACCINE COMPOSITION FOR MUCOSAL ADMINISTRATION - The present invention provides a cancer vaccine composition for mucosal administration comprising (i) a HER2/neu E75 peptide and/or a modified HER2/neu E75 peptide; and (ii) a first cellular immunity induction promoter. | 08-07-2014 |
20140220100 | VACCINE COMPOSITION FOR TRANSDERMAL ADMINISTRATION - The invention provides a cancer vaccine composition for transdermal administration for inducing cellular immunity comprising (i) HER2/neu E75 peptide and/or a modified HER2/neu E75 peptide; and (ii) a first cellular immunity induction promoter. | 08-07-2014 |
20140220105 | TAPE PREPARATION OF WT1 PEPTIDE CANCER VACCINE FOR TRANSDERMAL ADMINISTRATION - The present invention provides a cancer vaccine tape preparation for inducing cellular immunity, comprising:
| 08-07-2014 |
20140234377 | VACCINE COMPOSITION FOR MUCOSAL ADMINISTRATION - The present invention provides a vaccine composition which comprises a cellular immunity induction promoter universally usable against various antigens in cellular immunity induction by mucosal administration of the antigen and exerts a high cellular immunity inducing effect by mucosal administration. The present invention provides a vaccine composition for mucosal administration to induce cellular immunity, comprising: (i) an antigen; and (ii) one or more cellular immunity induction promoters selected from the group consisting of a TLR ligand, a cyclic dinucleotide, a helper peptide and an immunomodulatory small molecule drug. | 08-21-2014 |
Patent application number | Description | Published |
20080305979 | Cleaning agent for removing solder flux and method for cleaning solder flux - The present invention provides a cleaning agent for removing the solder flux and method for cleaning the solder flux which exhibit the excellent cleaning property even at the time of cleaning a lead-free soldering flux, a high-melting-point solder flux or the like and, at the same time, exhibits the excellent rinsing property in the rinsing using an alcoholic solvent in a next step. Accordingly, the present invention provides a cleaning agent for removing the solder flux which sets a content of benzyl alcohol to a value which falls within a range of 70 to 99.9 weight % and a content of amino alcohol to a value which falls within a range of 0.1 to 30 weight % when a content of a glycol compound is below 1 weight % with respect to a total amount of the cleaning agent for removing the solder flux, and sets a content of benzyl alcohol to a value which falls within a range of 15 to 99 weight % and a content of amino alcohol to a value which falls within a range of 0.1 to 30 weight % when a content of the glycol compound falls within a range of 1 to 40 weight % with respect to a total amount of the cleaning agent for removing the solder flux. The cleaning agent for removing the solder flux is used for cleaning the lead-free solder flux and the high-melting-point solder flux or the like. | 12-11-2008 |
20130096044 | LIQUID CONCENTRATE FOR CLEANING COMPOSITION, CLEANING COMPOSITION AND CLEANING METHOD - Provided is a liquid concentrate for cleaning composition which could exhibit excellent environmental safety etc. by adding afterward a predetermined amount of water, and also has excellent regeneration efficiency, and provided are a cleaning composition and a cleaning method thereof. Disclosed is a liquid concentrate for cleaning composition which is used as a mixture with water and is intended for cleaning an object to be cleaned in a clouded state, with a predetermined amount of water having been added thereto, the liquid concentrate for cleaning composition including, a first organic solvent which is a predetermined hydrophobic glycol ether compound or the like, and a second organic solvent which is a predetermined hydrophilic amine compound. | 04-18-2013 |
20150115018 | CONDUCTIVE PASTE AND DIE BONDING METHOD - Provided are: a conductive paste in which sinterability of silver particles the conductive paste can be easily controlled by using silver particles having predetermined crystal transformation characteristics defined by an XRD analysis, and after a sintering treatment, excellent electrical conductivity and thermal conductivity can be stably obtained; and a die bonding method using the conductive paste. | 04-30-2015 |
Patent application number | Description | Published |
20090207299 | ELECTRONIC CAMERA - An electronic camera includes an imaging device. The imaging device has an imaging surface capturing an object scene through a focus lens and repeatedly produces an object scene image. The focus lens is moved in an optical-axis direction in parallel with a process of the imaging device. A high-frequency component of the object scene image is extracted by a focus evaluation circuit in parallel with moving of the focus lens. A CPU specifies lens positions respectively corresponding to local maximum values found from the extracted high-frequency component. When an interval ΔF between the specified lens positions falls below a threshold value, the focus lens is placed at a lens position on the nearest side, out of the specified lens positions. When the interval ΔF is equal to or more than the threshold value, the focus lens is placed at a position different from the lens position on the nearest side. | 08-20-2009 |
20100254691 | ELECTRONIC CAMERA - An electronic camera includes an imaging device. The imaging device includes an imaging surface capturing an object scene through a focus lens, and produces an object scene image in a designated cycle. When a shutter button is half-depressed, an adjuster adjusts a position of the focus lens based on the object scene image produced by the imaging device. Also, a determiner determines whether or not both an illuminance and a contrast of the object scene captured by the imaging surface fall below a reference in association with a position adjusting process of the focus lens, and a controller sets a length of the designated cycle when a determination result is affirmative to be longer than that of the designated cycle when the determination result is negative. | 10-07-2010 |
20100295986 | ELECTRONIC CAMERA - An electronic camera includes an imager which outputs an object scene image in a designated cycle. The first changer changes a distance from a focus lens to the imaging surface. The first adjustor adjusts the designated cycle to a length corresponding to an illuminance of the object scene in association with a process of the first changer. The first specifier specifies a distance range including a focal point in parallel with the process of the first changer. The second changer changes the distance from the focus lens to the imaging surface in the distance range specified by the first specifier. The second adjustor adjusts the designated cycle to a length corresponding to a contrast of the object scene in association with a process of the second changer. The second specifier specifies the distance corresponding to the focal point in parallel with the process of the second changer. | 11-25-2010 |
Patent application number | Description | Published |
20080242656 | N-Substituted-N-Sulfonylaminocyclopropane Compounds and Pharmaceutical Use Thereof - The present invention provides a compound having aggrecanase inhibitory activity and MMP-13 inhibitory activity, and useful as a therapeutic agent for osteoarthritis, rheumatoid arthritis and the like, more specifically, a N-substituted-N-sulfonylaminocyclopropane compound of formula (1) | 10-02-2008 |
20080261994 | CYCLOPROPANE COMPOUNDS AND PHARMACEUTICAL USE THEREOF - The present invention provides a compound having aggrecanase inhibitory activity and MMP-13 inhibitory activity, and useful as a therapeutic agent for osteoarthritis, rheumatoid arthritis and the like, more specifically, a cyclopropane compound of formula (1): | 10-23-2008 |
20080306258 | Cyclopropane compounds and pharmaceutical use thereof - The present invention provides a compound having aggrecanase inhibitory activity and MMP-13 inhibitory activity, and useful as a therapeutic agent for osteoarthritis, rheumatoid arthritis and the like, more specifically, a cyclopropane compound of formula (1): | 12-11-2008 |
20100105894 | Cyclopropane compounds and pharmaceutical use thereof - The present invention provides a compound having aggrecanase inhibitory activity and MMP-13 inhibitory activity, and useful as a therapeutic agent for osteoarthritis, rheumatoid arthritis and the like, more specifically, a cyclopropane compound of formula (1): | 04-29-2010 |
20150183812 | PYRIMIDINE COMPOUND AND MEDICAL USE THEREOF - The present invention relates to a pyrimidine compound or a pharmaceutically acceptable salt thereof represented by the following formula [I] | 07-02-2015 |